Verona Pharma plc 4 SEC Filings

Filed On	Filing
08 Oct 2025	Form 4: Fisher Andrew, General Counsel Returned 1,349,887 shares to the issuer · Received 931,984 shares by exercise or conversion · Granted 618,760 Restricted Share Unit · 1 more
08 Oct 2025	Form 4: Zaccardelli David, Director Returned 15,461,424 shares to the issuer · Received 3,285,280 shares by exercise or conversion · Granted 1,649,952 Restricted Share Unit
08 Oct 2025	Form 4: Rickard Kathleen A., Chief Medical Officer Returned 3,564,852 shares to the issuer · Received 1,131,984 shares by exercise or conversion · Granted 618,760 Restricted Share Unit · 1 more
08 Oct 2025	Form 4: Hahn Mark W, Chief Financial Officer Returned 14,550,248 shares to the issuer · Received 3,285,280 shares by exercise or conversion · Granted 1,649,952 Restricted Share Unit
08 Oct 2025	Form 4: Austwick Michael, Director Returned 84,712 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 144,000 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Ullman Anders, Director Returned 430,856 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 600,000 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Shah Mahendra, Director Returned 165,472 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 600,000 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Sinha Vikas, Director Returned 166,112 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 400,384 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Deschamps Lisa, Director Returned 156,856 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 600,000 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Ebsworth David R, Director Returned 1,570,099 shares to the issuer · Received 72,000 shares by exercise or conversion
08 Oct 2025	Form 4: Edwards Martin, Director Returned 229,992 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 600,000 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Brady James Aloysius, Director Returned 95,176 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 624,000 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Cunningham Kenneth, Director Returned 151,776 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 600,000 Share Options (Right to Buy) (Disposition to Issuer)
08 Oct 2025	Form 4: Ackermann Christina, Director Returned 136,072 shares to the issuer · Received 72,000 shares by exercise or conversion · Disposed of 344,000 Share Options (Right to Buy) (Disposition to Issuer)
03 Sep 2025	Form 4: Zaccardelli David, Director Gave 1,200,000 shares as a gift
03 Sep 2025	Form 4: Rickard Kathleen A., Chief Medical Officer Gave 189,600 shares as a gift
03 Sep 2025	Form 4: Hahn Mark W, Chief Financial Officer Gave 1,200,000 shares as a gift
05 Aug 2025	Form 4: Cunningham Kenneth, Director Received 24,000 shares by exercise or conversion · Sold 10,808 shares ($142K)
05 Aug 2025	Form 4: Deschamps Lisa, Director Received 24,000 shares by exercise or conversion · Sold 9,464 shares ($124K)
05 Aug 2025	Form 4: Fisher Andrew, General Counsel Received 20,888 shares by exercise or conversion · Sold 9,584 shares ($126K)

Comments